Search
for
Sort by
Research 451–480 of 1000+
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Graft-versus-host disease
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- An Overview of Alopecias
- Oral Retinoids in Dermatology
- Microneedle-Based Approaches for Skin Disease Treatment
- Alopecia With Endocrine Therapies in Patients With Cancer
- TOXIC EPIDERMAL NECROLYSIS
- Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems
- Trichodysplasia of immunosuppression treated with oral valganciclovir
- Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection
- Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
- Prenatal serological diagnosis of intrauterine cytomegalovirus infection.
- Interventions for female pattern hair loss
- Parathyroid Hormone Hormone-Related Protein and the PTH Receptor Regulate Angiogenesis of the Skin
- Chaos and antichaos in pathology
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- <i>Pten</i> loss in Lgr5<sup>+</sup> hair follicle stem cells promotes SCC development
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Venous thromboembolism and women's health
- What is the Rationale for Androgen Therapy for Women?
- The effect of platelet-rich plasma on female androgenetic alopecia: A randomized controlled trial
- Dermatologic Problems of Older Women
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- From Surgery to Pharmacology to Gene Therapy
- Clinical Development of Topoisomerase-Interactive Drugs
- Nonmalignant late cutaneous changes after allogeneic hematopoietic stem cell transplant in children
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Materials, Syntheses and Biomedical Applications of Nano-Quercetin Formulations: A Comprehensive Literature Review